Chr. Hansen Holding Past Earnings Performance
Past criteria checks 3/6
Chr. Hansen Holding's earnings have been declining at an average annual rate of -0.8%, while the Chemicals industry saw earnings growing at 18.3% annually. Revenues have been growing at an average rate of 5.6% per year. Chr. Hansen Holding's return on equity is 11.9%, and it has net margins of 17%.
Key information
-0.8%
Earnings growth rate
-0.9%
EPS growth rate
| Chemicals Industry Growth | 13.1% |
| Revenue growth rate | 5.6% |
| Return on equity | 11.9% |
| Net Margin | 17.0% |
| Next Earnings Update | 04 Apr 2024 |
Recent past performance updates
Recent updates
Be Wary Of Chr. Hansen Holding (CPH:CHR) And Its Returns On Capital
Dec 31
Is Chr. Hansen Holding (CPH:CHR) Using Too Much Debt?
Dec 13Chr. Hansen Holding (CPH:CHR) Will Be Hoping To Turn Its Returns On Capital Around
Jun 26These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
May 21Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital
Mar 28Chr. Hansen Holding's (CPH:CHR) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 14Chr. Hansen Holding (CPH:CHR) Is Paying Out A Larger Dividend Than Last Year
Oct 29Chr. Hansen Holding (CPH:CHR) Is Increasing Its Dividend To €7.04
Oct 15Here's What's Concerning About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Sep 13These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
Aug 29A Look At The Intrinsic Value Of Chr. Hansen Holding A/S (CPH:CHR)
Aug 13Capital Allocation Trends At Chr. Hansen Holding (CPH:CHR) Aren't Ideal
Jun 12Chr. Hansen Holding (CPH:CHR) Seems To Use Debt Quite Sensibly
May 24A Look At The Fair Value Of Chr. Hansen Holding A/S (CPH:CHR)
May 09There Are Reasons To Feel Uneasy About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Mar 06Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?
Feb 19Revenue & Expenses BreakdownBeta
How Chr. Hansen Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Aug 23 | 1,334 | 227 | 269 | 99 |
| 31 May 23 | 1,310 | 229 | 269 | 99 |
| 28 Feb 23 | 1,294 | 229 | 268 | 98 |
| 30 Nov 22 | 1,259 | 228 | 263 | 98 |
| 31 Aug 22 | 1,218 | 225 | 256 | 97 |
| 31 May 22 | 1,183 | 230 | 248 | 96 |
| 28 Feb 22 | 1,146 | 221 | 238 | 96 |
| 30 Nov 21 | 1,102 | 209 | 232 | 93 |
| 31 Aug 21 | 1,077 | 199 | 228 | 90 |
| 31 May 21 | 1,038 | 199 | 213 | 80 |
| 28 Feb 21 | 1,014 | 213 | 202 | 77 |
| 30 Nov 20 | 994 | 222 | 193 | 74 |
| 31 Aug 20 | 970 | 232 | 188 | 73 |
| 31 May 20 | 798 | 218 | 160 | 69 |
| 29 Feb 20 | 844 | 221 | 174 | 70 |
| 30 Nov 19 | 888 | 224 | 184 | 71 |
| 31 Aug 19 | 937 | 229 | 193 | 70 |
| 31 May 19 | 1,152 | 246 | 228 | 76 |
| 28 Feb 19 | 1,132 | 240 | 223 | 75 |
| 30 Nov 18 | 1,112 | 233 | 218 | 74 |
| 31 Aug 18 | 1,097 | 228 | 210 | 73 |
| 31 May 18 | 1,084 | 226 | 208 | 74 |
| 28 Feb 18 | 1,080 | 224 | 206 | 73 |
| 30 Nov 17 | 1,075 | 224 | 206 | 72 |
| 31 Aug 17 | 1,063 | 224 | 205 | 70 |
| 31 May 17 | 1,035 | 212 | 199 | 67 |
| 28 Feb 17 | 1,007 | 205 | 193 | 65 |
| 30 Nov 16 | 976 | 192 | 183 | 63 |
| 31 Aug 16 | 949 | 184 | 179 | 60 |
| 31 May 16 | 927 | 179 | 175 | 57 |
| 29 Feb 16 | 905 | 174 | 170 | 54 |
| 30 Nov 15 | 885 | 172 | 168 | 53 |
| 31 Aug 15 | 859 | 163 | 163 | 51 |
| 31 May 15 | 830 | 150 | 158 | 49 |
| 28 Feb 15 | 800 | 141 | 152 | 46 |
| 30 Nov 14 | 773 | 133 | 150 | 45 |
| 31 Aug 14 | 756 | 132 | 147 | 43 |
| 31 May 14 | 745 | 145 | 148 | 42 |
| 28 Feb 14 | 738 | 142 | 150 | 40 |
| 30 Nov 13 | 731 | 135 | 151 | 37 |
| 31 Aug 13 | 738 | 138 | 152 | 35 |
| 31 May 13 | 730 | 126 | 166 | 20 |
| 28 Feb 13 | 719 | 125 | 158 | 24 |
Quality Earnings: CHR has high quality earnings.
Growing Profit Margin: CHR's current net profit margins (17%) are lower than last year (18.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CHR's earnings have declined by 0.8% per year over the past 5 years.
Accelerating Growth: CHR's earnings growth over the past year (0.8%) exceeds its 5-year average (-0.8% per year).
Earnings vs Industry: CHR earnings growth over the past year (0.8%) exceeded the Chemicals industry -15.9%.
Return on Equity
High ROE: CHR's Return on Equity (11.9%) is considered low.